Vimarsana
Biggest News Aggregation in the World

Page 43 - Ouse Model News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ouse Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ouse Model Today - Breaking & Trending Today

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious - Vimarsana News

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Researchers compared the efficiency of monovalent and bivalent mRNA vaccines against SARS-CoV-2.

Type I interferon found to be major driver of memory, cognitive loss in Alzheimer's disease mouse model - Vimarsana News

Type I interferon found to be major driver of memory, cognitive loss in Alzheimer's disease mouse model

Alzheimer's disease (AD), the most common type of dementia, progressively impairs memory, concentration and the ability to learn new things and accomplish everyday activities.

UCL researchers boost the effectiveness of therapeutic vaccine for chronic HBV - Vimarsana News

UCL researchers boost the effectiveness of therapeutic vaccine for chronic HBV

Scientists at UCL have significantly boosted the effectiveness of a therapeutic vaccine designed to control chronic hepatitis B (HBV) infection, after uncovering and thwarting 'the enemy within'.

Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice - Vimarsana News

Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice

A recent article presented the diverse pathogenesis of SARS-CoV-2 variants of concern in a humanized mouse model.

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease - Vimarsana News

Modified version of hormone kisspeptin can be used to treat non-alcoholic fatty liver disease

A hormone that triggers puberty and controls fertility in humans might be developed as a treatment for non-alcoholic fatty liver disease, according to new Rutgers research.